Dr. Donna Skerrett, CEO, Paradigm Biopharmaceuticals Ltd 00:00:00
Paradigm Biopharmaceuticals Ltd Chief Medical Officer and Interim CEO Dr. Donna Skerrett tells Proactive the Melbourne, Australia-based clinical stage biopharmaceutical company has been granted Fast Track Designation for the company’s phase 3 program to treat osteoarthritis.